The opioids market is projected to experience a robust compound annual growth rate (CAGR) of 2.50% over the forecast period, ultimately reaching a value of US$ 35.16 billion by 2030.This significant growth can be attributed to factors such as increasing prevalence of chronic pain conditions, rising demand for effective pain management solutions, and the expanding geriatric population worldwide. Additionally, advancements in drug delivery systems and continuous research and development efforts are expected to contribute to the market's growth. However, the market also faces challenges related to the potential for misuse, addiction, and regulatory concerns, which require careful monitoring and control measures.
Omega 3 Supplements Market By Source (Fish Oil, Krill Oil, and Others (Flaxseeds and Mung Beans)), By Application (Infant Formula, Food and Beverage, Nutritional Supplements, Pharmaceuticals, Pet and Animal Feed, and Clinical Nutrition), and By Region (North America, Europe, Asia Pacific, Latin America, Middle East, and Africa) - Trends, Analysis and Forecast till 2029
Sample link:
https://www.prophecymarketinsights.com/market_insight/Insight/request-sample/253
Key Highlights:

• In 2018, Allergan acquired Elastagen, to the manufacturer of skin augmentation products.

Analyst view:
According to industry analysts, the global opioids market is poised for steady growth in the coming years. Factors such as the rising prevalence of chronic diseases, including cancer and arthritis, are expected to drive the demand for opioids as effective pain management solutions. Additionally, the increasing geriatric population, which is more prone to chronic pain conditions, is likely to contribute to market growth.
Analysts also highlight the advancements in drug delivery systems, such as transdermal patches and extended-release formulations, which offer improved convenience and efficacy. These innovations are anticipated to further propel the market expansion. Moreover, ongoing research and development activities focused on developing safer and more abuse-deterrent opioid formulations are expected to enhance the market's attractiveness.
Competitive position:
The prominent player operating in the global opioids market includes Allergan, Egalet Corporation, Endo Pharmaceuticals Inc., Janssen Pharmaceuticals Inc., Mallinckrodt, Pfizer Inc., Purdue Pharma LP, Vertice Pharma LLC, Sun Pharmaceutical Industries Ltd., and Teva Pharmaceutical Industries Ltd.
To know more
Contact Us:
Sales
Prophecy Market Insights
U.S: 1 860 531 2574
RoW: 91 7775049802
Email- [email protected]
Website- www.prophecymarketinsights.com
Blog- www.prophecyjournals.com